Skip to main navigation Skip to search Skip to main content

Inhibition of tau aggregation by the CCT3 and CCT7 apical domains

Research output: Contribution to journalArticlepeer-review

Abstract

The eukaryotic chaperonin containing t-complex polypeptide 1 (CCT/TRiC) is a molecular chaperone that assists protein folding in an ATP-driven manner. It consists of two stacked identical rings that are each made up of eight distinct subunits. Here, we show that the apical domains of subunits CCT3 and CCT7 from humans are strong inhibitors of tau aggregation, which is associated with several neurological disorders such as Alzheimer's and Parkinson's diseases. Kinetic analyses and negative-stain electron microscopy indicate that the mechanism of inhibition of tau aggregation by the apical domains of subunits CCT3 and CCT7 differ. Aggregation of tau alone, or in the presence of the apical domain of subunit CCT7, can be described by a fragmentation model whereas in the presence of the apical domain of subunit CCT3, it fits a saturating elongation and fragmentation mechanism. Coarse-grained molecular dynamics simulations show that tau interacts with different regions in the apical domains of subunits CCT3 and CCT7, in agreement with their different inhibition mechanisms.

Original languageEnglish
Article numbere70162
JournalProtein Science
Volume34
Issue number6
Early online date22 May 2025
DOIs
StatePublished - 1 Jun 2025

Keywords

  • Alzheimer's disease
  • CCT/TRiC
  • chaperonins
  • protein aggregation
  • tau

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Fingerprint

Dive into the research topics of 'Inhibition of tau aggregation by the CCT3 and CCT7 apical domains'. Together they form a unique fingerprint.

Cite this